小叶原位癌患者接受双侧乳房切除术或部分乳房切除术后的生存结局
基于SEER数据库5964例小叶原位癌患者,比较双侧乳房切除术(208例)与单纯部分乳房切除术(5756例)的生存结局。多因素分析显示两组全因死亡风险无显著差异(HR=1.106,95%CI 0.350-3.500,P=0.86),倾向性评分匹配后仍无获益(HR=2.248,95%CI 0.451-11.200)。作者认为部分乳房切除术不劣于双侧预防性乳房切除术,不主张对多数患者行积极预防性手术。
要点
- 双侧乳房切除术与部分乳房切除术的全因死亡风险无显著差异(HR=1.106,95%CI 0.350-3.500,P=0.86)。
- 倾向性评分匹配模型中双侧乳房切除术对总生存仍无获益(HR=2.248,95%CI 0.451-11.200)。
- 年龄大于60岁与更高的全因死亡风险相关(HR=7.593,95%CI 5.357-10.764,P<0.0001)。
核心结论
- 接受单纯部分乳房切除术(未放疗)的小叶原位癌患者生存结局不劣于接受双侧预防性乳房切除术的患者。
- 小叶原位癌患者的乳腺癌特异性死亡率极低;作者认为不应提倡对多数小叶原位癌患者行双侧预防性乳房切除术等积极预防性手术。
研究设计与样本
- 基于2016年发布的SEER*Stat数据库(8.3.2版)的回顾性分析,纳入组织学确诊为小叶原位癌、接受单纯部分乳房切除术或双侧乳房切除术的患者共5964例。
- 双侧乳房切除术组208例,单纯部分乳房切除术组5756例;主要结局为全因死亡率,次要结局为乳腺癌特异性死亡率。
主要发现
- 全组1年、5年和10年估计总生存率分别为99.7%、96.7%和91.7%。
- 单因素和多因素Cox比例风险回归分析显示,双侧乳房切除术组与部分乳房切除术组的全因死亡风险无显著差异(HR=1.106,95%CI 0.350-3.500,P=0.86)。
- 倾向性评分匹配模型中,双侧乳房切除术对总生存仍无获益(HR=2.248,95%CI 0.451-11.200)。
- 年龄大于60岁的患者全因死亡风险更高(HR=7.593,95%CI 5.357-10.764,P<0.0001)。
- 包括手术方式在内的任何因素均未显示与乳腺癌特异性生存相关。
临床怎么用
- 作者认为,小叶原位癌患者的乳腺癌特异性死亡率极低,不应提倡对多数小叶原位癌患者行双侧预防性乳房切除术等积极预防性手术。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
AIM: To compare the survival outcomes between patients treated with bilateral mastectomy and partial mastectomy alone as the initial surgical management for primary lobular carcinoma in situ (LCIS). PATIENTS AND METHODS: Patients with histologically confirmed LCIS underwent partial mastectomy alone or bilateral mastectomy were identified by the SEER*Stat database (version 8.3.2) released in 2016. The primary outcome measure was all-cause mortality and the secondary outcome measure was breast cancer-specific mortality. RESULTS: Of the 5964 cases included in the analysis, 208 cases underwent bilateral mastectomy and 5756 cases underwent partial mastectomy alone. The 1-, 5- and 10-year estimated overall survival rates were 99.7%, 96.7% and 91.7%, respectively. Univariate and multivariate proportional hazards regression (Cox) analyses showed no significant difference between the risk of all-cause mortality in the bilateral mastectomy group compared with the partial mastectomy group (HR = 1.106, 95% confidence interval [CI] 0.350-3.500, P = 0.86). In propensity score-matched model, bilateral mastectomy still did not show benefit to overall mortality (HR = 2.248, 95% CI 0.451-11.200). Patients older than 60 years of age showed a higher risk of all-cause mortality (HR = 7.593, 95% CI 5.357-10.764, P < 0.0001). No risk factors, including surgery type, were identified for breast cancer-specific survival. CONCLUSIONS: Survival outcomes of patients with LCIS who underwent partial mastectomy without radiotherapy were not inferior to patients who underwent bilateral prophylactic mastectomy. Breast cancer-specific mortality in patients with LCIS was extremely low; aggressive prophylactic surgery like bilateral prophylactic mastectomy should not be advocated for most patients with LCIS.
引用
- Xie ZM, Sun J, Hu ZY, et al. Survival outcomes of patients with lobular carcinoma in situ who underwent bilateral mastectomy or partial mastectomy. Eur J Cancer. 2017. PMID: 28646773. doi:10.1016/j.ejca.2017.05.030
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。